4503:TYO
Astellas Pharma Inc
¥2,292.50
arrow_upward
+2.32%(+52.00) 1D
Sep 14, 3:30:00 PM GMT+9 · JPY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4503...
Open
¥2,250
High
¥2,292
Low
¥2,237
Mkt. cap
4.15T
Avg. vol.
6.21M
Volume
4.22M
Dividend
3.40%
Quarterly dividend
¥19
Ex-dividend date
Sep 29, 2026
P/E ratio
11.25
52-wk high
¥2,717
52-wk low
¥1,558
EPS
¥204
Shares outstanding
1.92B
No. of employees
14K
Open
¥2,250
High
¥2,292
Low
¥2,237
Mkt. cap
4.15T
Avg. vol.
6.21M
Volume
4.22M
Dividend
3.40%
Quarterly dividend
¥19
Ex-dividend date
Sep 29, 2026
P/E ratio
11.25
52-wk high
¥2,717
52-wk low
¥1,558
EPS
¥204
Shares outstanding
1.92B
No. of employees
14K
News stories
From web sources and news partners
IDA Ireland
·
2 hours ago
Astellas strengthens commitment to Ireland with expanded investment in Tralee biopharmaceutical facility
Simply Wall Street
·
2 days ago
How Lower Medicaid Prices At Astellas Pharma Stock Has Changed Its Investment Story
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma Inc
CEONaoki Okamura
Employees14.1K
FoundedApr 1, 2005
HeadquartersChuo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteastellas.com